
A chronic neurological disorder affecting the brain's ability to control sleep-wake cycles, causing excessive daytime sleepiness and sudden sleep attacks.
Narcolepsy is a lifelong neurologic disorder characterized by the brain's inability to regulate sleep-wake cycles normally. Individuals with narcolepsy experience overwhelming daytime drowsiness and may have sudden, uncontrollable episodes of falling asleep during any type of activity. Some people with narcolepsy also experience sudden loss of muscle tone (cataplexy) triggered by strong emotions. Narcolepsy can significantly impact daily activities including work, school, social relationships, and safety, particularly when driving or operating machinery.
Narcolepsy affects approximately 1 in 2,000 people, though up to 50% of cases may be undiagnosed. It affects men and women equally. Symptoms typically begin between ages 15-25, but can occur at any age. The average delay from symptom onset to diagnosis is 8-10 years. While narcolepsy can run in families, most cases are not inherited.
Narcolepsy Type 1 is caused by loss of brain cells that produce hypocretin (also called orexin), a neurotransmitter that regulates wakefulness and REM sleep. This loss is thought to be autoimmune in nature, possibly triggered by infections (such as H1N1 flu) in genetically susceptible individuals. The cause of Narcolepsy Type 2 is less clear but may involve less severe hypocretin deficiency. Risk factors include family history (having a first-degree relative with narcolepsy increases risk 10-40 fold), certain infections, and brain injuries affecting the hypothalamus.
Characterized by excessive daytime sleepiness plus cataplexy (sudden muscle weakness triggered by emotions), or by low cerebrospinal fluid hypocretin-1 levels.
Features excessive daytime sleepiness without cataplexy and with normal or near-normal hypocretin levels. May be a precursor to Type 1 in some cases.
The primary symptom is persistent sleepiness regardless of how much nighttime sleep you get. This overwhelming urge to sleep can occur at any time and is difficult to prevent. Brief naps may provide temporary relief.
Sudden loss of muscle tone while awake, triggered by strong emotions like laughter, surprise, or anger. Ranges from mild weakness (drooping eyelids, slurred speech) to complete body collapse. Only occurs in Type 1 narcolepsy.
Temporary inability to move or speak while falling asleep or waking up, lasting seconds to minutes. Can be frightening but is not dangerous.
Vivid, dream-like experiences occurring when falling asleep (hypnagogic) or waking up (hypnopompic). Often visual but can involve any sense. Can be frightening and feel very real.
Despite excessive daytime sleepiness, many people with narcolepsy have fragmented nighttime sleep with frequent awakenings.
Continuing routine tasks (writing, driving, eating) during brief sleep episodes without awareness or memory of the activity.
Difficulty focusing, memory lapses, and cognitive fog due to intrusion of sleep into wakefulness.
If you answer yes to any of these questions, consider consulting a sleep specialist:
Diagnosis requires demonstration of excessive sleepiness and assessment for cataplexy and other symptoms. Sleep studies are essential for confirming the diagnosis and ruling out other causes of sleepiness.
An overnight sleep study rules out other sleep disorders (especially sleep apnea) and documents sleep patterns. People with narcolepsy often enter REM sleep abnormally quickly.
Conducted the day after polysomnography, the MSLT involves 4-5 scheduled nap opportunities. Narcolepsy is indicated by falling asleep in less than 8 minutes on average and entering REM sleep during 2 or more naps.
A spinal tap to measure hypocretin levels can confirm Type 1 narcolepsy. Very low or absent levels are diagnostic, even without cataplexy.
Testing for HLA-DQB1*06:02, a genetic marker present in most people with Type 1 narcolepsy. However, this marker is also present in 25% of the general population, so it's not diagnostic alone.
While there is no cure for narcolepsy, symptoms can be managed with medications and lifestyle modifications. Treatment is tailored to address the specific symptoms each person experiences.
Modafinil (Provigil) and armodafinil (Nuvigil) are first-line treatments for daytime sleepiness. Other options include solriamfetol (Sunosi), pitolisant (Wakix), and traditional stimulants like methylphenidate and amphetamines.
Taken at night, sodium oxybate improves nighttime sleep and reduces both daytime sleepiness and cataplexy. It's one of the most effective treatments for narcolepsy but requires careful monitoring.
SSRIs, SNRIs, and tricyclic antidepressants can suppress REM sleep and reduce cataplexy, sleep paralysis, and hallucinations. Common options include venlafaxine, fluoxetine, and clomipramine.
Planned short naps (15-20 minutes) at strategic times during the day can help manage sleepiness and reduce the need for higher medication doses.
Research continues on orexin replacement therapy and other novel approaches that may offer new treatment options in the future.
Search our directory for sleep clinics that specialize in treating narcolepsy.
Search Clinics